PEAK1 and familial pancreatic carcinoma: Additionally, we’ve reported that the translation factor eIF5A drives PEAK1 protein production and can be targeted with the FDA-approved anti-fungal agent Cyclopirox Olamine (CPX) to both decrease cellular PEAK1 levels and abrogate pancreatic cancer cell growth [39].